Digital therapeutics and pharma: A blueprint for success from Sanofi’s Bozidar Jovicevic

Mckinsey, 18/02/2020

Partagé par : 

Isabelle de cuniac

Isabelle De cuniac

Digital therapeutics and pharma: A blueprint for success from Sanofi’s Bozidar Jovicevic

"The head of digital therapeutics at Sanofi, Bozidar Jovicevic, spoke with McKinsey partner Ivan Ostojic on how digital therapeutics will change the future of healthcare—and the bold moves Sanofi has taken to meet that future. The following are excerpts from their conversation. McKinsey: How would you define digital therapeutics? Bozidar Jovicevic: There’s no standard definition. At Sanofi, we define them as nonpharmacological, tech-focused solutions that..." Lire la suite